S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

High Tide Expands German Medical Cannabis Footprint via Remexian

At the Mary Jane Berlin trade show held June 11–14, Remexian Pharma showcased its growing portfolio of exclusive Canadian cannabis brands. The High Tide subsidiary is leveraging these partnerships to solidify its position as a primary importer in the German medical market, connecting premium producers directly with local pharmacists and patients.

High Tide Expands German Medical Cannabis Footprint via Remexian
Photo: Bio & News

The Berlin event served as a tactical stage for Remexian to highlight its distribution agreements with brands including Tribal, Highly Dutch Organic, Weed Me, The Loud Plug, Joi Botanicals, and Castle Rock Farms. By facilitating these direct links to the German healthcare sector, the company aims to address a clear demand for differentiated, high-quality cannabis products in one of Europe’s most rapidly evolving regulatory environments.

Raj Grover, founder and CEO of High Tide, noted that the reception in Berlin validates the firm’s strategy of exporting Canadian procurement expertise to international markets. With Remexian currently holding a 14% share of the German medical cannabis market, the subsidiary is scaling its pharmacy network and deepening relationships with medical professionals to secure a larger portion of the regional supply chain.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!